Breast cancer is one of the most commonly diagnosed invasive cancers. Established risk factors account for only a small proportion of cases. Previous studies have found reductions in sleep duration and quality in the general population over time. There is evidence to suggest a link between poor sleep and an increased risk of breast cancer. In this study, we investigated the relationship between breast cancer and sleep duration and quality in Western Australian women. Data were obtained from a population-based case-control study conducted from 2009 to 2011. Participants completed a self-administered questionnaire that included questions on sleep. Odds ratios and 95% confidence intervals were calculated using unconditional logistic regression. Sensitivity analysis for potential selection and misclassification bias was also conducted. We found no association between self-reported sleep duration on workdays and risk of breast cancer (for <6 hours, odds ratio (OR) = 1.05 (95% CI: 0.82, 1.33); for 6-7 hours, OR = 0.96 (95% CI: 0.80, 1.16); and for >8 hours, OR = 1.10 (95% CI: 0.87, 1.39), compared with the reference category of 7-8 hours' sleep). In addition, we found no association between sleep duration on nonworkdays, subjective sleep quality, or combined duration and quality and risk of breast cancer. This study does not provide evidence to support an association between self-reported sleep duration or quality and the risk of breast cancer.
Editor's note: An invited commentary on this article appears on page 328 and the authors' response appears on page 331.
Breast cancer is the most commonly diagnosed invasive cancer and the leading cause of cancer death among women, both in Australia and globally (1, 2) . While some risk factors, such as primary genetic mutations, reproductive history, weight gain, and alcohol consumption, are well established, they do not account for a significant proportion of breast cancer cases (2) .
Both international and Australian studies have reported changes in sleep over time in developed countries. Some studies have suggested a reduction in habitual sleep duration of 13-36 minutes over the last 20-30 years (3-7), although reductions in sleep duration have not been consistently found (8, 9) . Studies of sleep quality have reported increases in the prevalence of subjective poor-quality sleep ranging from 5% to almost 40% (3, 4, 10) .
While the immediate effects of poor sleep, such as tiredness, loss of concentration, and injuries, are well recognized (11) , the chronic effects of poor sleep have not been extensively studied. However, there is some evidence to suggest a link between poor sleep and a range of long-term health effects, including increased risk of cancer (12) (13) (14) (15) (16) (17) (18) .
Two plausible biological models have been proposed that would explain how poor sleep can directly influence the development of cancer: impaired immune function and metabolic pathways that lead to obesity (2, 12, 15, 19 ). An additional indirect mechanism has also been proposed which suggests an increased risk of cancer due to altered melatonin release (20, 21) . Melatonin release is regulated by the light/dark cycle rather than by sleep per se, and previous studies have used sleep as a proxy for "exposure to darkness" (22) . All 3 proposed pathways have some evidence to support them, but the true process by which sleep might influence cancer risk is unknown.
Five studies have investigated the relationship between sleep duration and breast cancer and have shown mixed results (22) (23) (24) (25) (26) . Kakizaki et al. (23) reported a statistically significant trend of decreasing risk with increasing sleep duration, while McElroy et al. (24) reported a statistically significant trend of increasing risk with increasing duration. The 3 remaining studies also found significant trends, but only after study populations were restricted or polytomous analysis was conducted (22, 25, 26) . Only 1 of those studies also examined subjective sleep quality (22) ; no association with breast cancer was found.
Our aim in this study was to investigate the relationship between breast cancer and 3 domains of sleep (sleep duration on workdays, sleep duration on nonworkdays, and subjective sleep quality) in a population of Western Australian women.
MATERIALS AND METHODS
The Breast Cancer Environment and Employment Study was a case-control study of occupational and environmental risk factors for breast cancer conducted in Western Australia. A sample size of 1,000 cases and 2,000 age-matched controls was calculated a priori based on the expected number and recruitment rate of incident breast cancer patients in Western Australia, the prevalence of exposure to shift work (the main study hypothesis), and the increased risk of breast cancer we expected to detect. The study was approved by the human research ethics committees of the Western Australian Department of Health and The University of Western Australia.
Cases
Cases were female residents of Western Australia aged 18-80 years with a first incident invasive breast cancer (International Classification of Diseases, Tenth Revision, code C50) that was diagnosed between May 1, 2009, and January 31, 2011, and reported to the Western Australian Cancer Registry before July 31, 2011. The Western Australian Cancer Registry is a population-based cancer registry that was established in 1981. Notification of cancer cases (excluding skin-primary basal cell carcinoma and squamous cell carcinoma) is mandatory for pathologists, hematologists, and radiation oncologists. Cases were excluded if the breast cancer was not invasive (i.e., ductal carcinoma in situ); if diagnosis had occurred more than 6 months prior to the date on which the Western Australian Cancer Registry received the notification; or if the patient had inadequate comprehension of English to complete the questionnaire. Of the 2,089 eligible breast cancer cases identified, 1,205 women (58%) consented to participate. Of the eligible cases who did not participate, 334 (16%) refused, 545 (26%) did not respond, and 5 had died. Compared with participants, those who refused to participate were older, while those who did not respond were younger. In addition, women who did not respond were more likely to live in very remote areas (4% vs. 2%). There were no differences in socioeconomic status between breast cancer patients who participated and those who refused or did not respond to the study invitation.
Controls
Controls were women aged 18-80 years living in Western Australia between May 2009 and July 2011 who were randomly selected from the electoral roll. They were frequency-matched to the expected distribution of cases by 5-year age group. Being registered to vote is compulsory in Australia, and the electoral roll is considered an almost complete list of Australian citizens. Controls were ineligible if they had had a previous diagnosis of invasive breast cancer or did not speak adequate English to complete the questionnaire. From a total of 4,358 eligible controls, 1,789 (41%) consented to participate. Of the eligible controls who did not participate, 939 (22%) refused, 1,628 (37%) did not respond, and 2 had died. Compared with participants, those who refused were older, while those who did not respond were younger. There were no differences in residential remoteness or socioeconomic status between control women who participated and those who refused or did not respond to the study invitation.
Data collection
We asked participants to complete a self-administered postal questionnaire that contained questions on demographic, reproductive, and lifestyle factors as well as sleep. The domains of sleep investigated were: usual duration of sleep on workdays; usual duration of sleep on nonworkdays; and subjective sleep quality. Specifically, the questions were: "Ignoring the last year, how many hours of sleep on [nonwork/work] days do you usually get?"; "Ignoring the last year, do you generally consider yourself to be a good sleeper; that is, do you fall asleep easily and sleep soundly?" We prefaced the questions with the words "Ignoring the last year…" in order to avoid identifying recent sleep habits that might be associated with underlying disease in cases.
Answer categories for the sleep duration questions were <5 hours, 5-6 hours, 6-7 hours, 7-8 hours, 8-9 hours, and >9 hours. There is a widely held but scientifically unsupported view that the normal/optimal sleep duration is 8 hours per night (27) . These nonexclusive answer categories were used to try to discourage participants from reflexively giving a "normative" answer (e.g., 8 hours) and to allow participants to consider the variability in their sleep and the direction in which this variability was more likely to occur. Answer categories such as "7-7.9 hours" have recently been criticized in the context of sleep research for forcing participants into answering with a level of precision that is inconsistent with a quantitative estimate of a highly variable trait (28) . Answer categories for the sleep quality questions were: very good sleeper; fairly good sleeper; fairly bad sleeper; and very bad sleeper. In addition, we created a categorical variable that combined sleep duration on workdays with 2 categories of sleep quality (good and bad) to investigate any joint effect of sleep length and quality.
Statistical analysis
Odds ratios and 95% confidence intervals were calculated using unconditional logistic regression, with the frequencymatched variable age included in all models. Variables thought to be associated with both the outcome and the exposure were considered "probable confounders" and were included in multivariable models regardless of any univariate association with the outcome. Variables thought to be associated with either the outcome or the exposure (but not both) were considered "possible confounders" and were included in the multivariate models if a χ 2 test of their univariate association with the outcome resulted in a P value of 0.25 or less.
The "possible confounders" were: country of birth, education, family history of breast cancer, previous breast conditions, use of oral contraceptives in the last 5 years, and circadian amplitude. The possible confounders were then assessed for their contribution to the fully adjusted multivariable effect size by means of a user-written Stata program (StataCorp LP, College Station, Texas) (29) . None of the possible confounders contributed to a change in the odds ratio of more than 5%, and as such they were excluded from the final multivariable model. "Probable confounders" included in the final multivariable model were: age, in 5-year groups; number of children; age at first birth; whether children were breastfed; menopausal status; use of physician-prescribed hormone replacement therapy; duration of use of hormone replacement therapy; usual alcohol consumption (glasses per week); comparative weight at age 30 years (compared with others of the same age and height); ever use of melatonin; and total physical activity in metabolic equivalents per week (quartiles).
Polytomous regression models were used to determine odds ratios according to the menopausal status ( pre-or post-) of cases at the time of diagnosis relative to controls and for estrogen receptor-positive/estrogen receptor-negative cases relative to controls (30, 31) .
Stratified analysis was also conducted for 3 characteristics of the circadian rhythm ( phase, amplitude, and stability) (32, 33) . The phase of the circadian rhythm is commonly recognized as a preference for being active in either the morning or the evening and was measured using the Horne-Ostberg Morningness/Evening questionnaire (34), with cutpoints developed by Taillard et al. (35) . The amplitude and stability of the rhythm are increasingly being recognized as potential factors in adjustment to shift work (32, 33) . The Circadian Type Inventory reports the amplitude of the rhythm as languidness or vigorousness (languidness/vigorousness scale). Lower scores on the languidness/vigorousness scale indicate a tendency toward vigorousness, representing the ability to more easily overcome drowsiness, while higher scores indicate a tendency toward languidness. The stability of the rhythm is reported as the flexibility or rigidity of sleeping habits (flexibility/ rigidity scale). Lower scores on the flexibility/rigidity scale are indicative of more rigid habits, conceptualized as an affinity for routine sleeping and eating times, while higher scores indicate increasing flexibility (32, 33) . The Circadian Type Inventory sets the cutpoints for both scales at the 25th and 75th percentiles, with the middle 50% of each scale defined as "neither." Differing sleep need and responses to sleep disturbance have been reported within the subtypes of all 3 characteristics (33, 36) .
Selection bias. Information on age (in 5-year groups), socioeconomic status (as defined by the Australian Bureau of Statistics Socio-Economic Indexes for Areas quintiles of advantage-disadvantage) (37) , and residential remoteness (as defined by the Accessibility/Remoteness Index of Australia) (38) was available for nonparticipants. To investigate selection bias, we recalculated the age-adjusted odds ratios after making two assumptions about sleep duration and quality in nonparticipants. The first assumption was that nonparticipants might be more likely to be "better" sleepers than participants (sleep duration 7-8 hours; sleep quality very good or fairly good). The second assumption was that people who did not consent might be "worse" sleepers (sleep duration <6 hours; sleep quality very bad or fairly bad), while those who did not respond might be "better" sleepers (sleep duration >8 hours or 7-8 hours; sleep quality very good or fairly good), in comparison with people who participated. This second assumption was based on the age differences between participants, nonconsenters, and nonresponders in this study and the association between increasing age and decreasing sleep duration and quality (39) . Under these two assumptions, 7 scenarios for nonparticipant sleep were developed and assessed.
Misclassification bias. Self-reported data are potentially subject to misclassification, and because our exposure variables were categorical, even random misclassification could have resulted in bias in any direction (40) . Studies of exposure misclassification have found that most of the error occurs within adjacent categories (41) . For sleep quality, we investigated the impact of various levels of 1-category nondifferential misclassification on our unadjusted odds ratios using the method described by Marshall et al. (42) . For the analysis of misclassification of sleep duration, we used a modified version of the method described by Marshall et al. (42) . A validity study of the sleep questionnaire used in this study (43) and supported by Patel et al. (44) found that the bias in self-reported duration was pointing away from the median. We recalculated odds ratios using varying levels of misclassification, where misclassified participants could only move towards the reference group (7-8 hours).
All statistical analysis was conducted using Stata 12 or Microsoft Excel 2010 (Microsoft, Redmond, Washington), and all statistical tests were 2-sided.
RESULTS
Of the 2,994 participants who completed the study, approximately 5% had missing data, leaving 2,828 for sleep duration analysis and 2,827 for sleep quality analysis. For the polytomous model, information on estrogen receptor status was not available for 169 women with breast cancer, and they were excluded from this analysis.
After the distribution of sleep durations was reviewed, fewer than 5% of participants fell into the first and last categories, and thus the results were condensed into 4 categories for analysis: <6 hours, 6-7 hours, 7-8 hours (reference category), and >8 hours.
The prevalences of diagnosed sleep apnea (2.5%), insomnia (2.9%), restless legs (2.6%), and other sleep disorders (<1%) in this sample were consistent with those reported in the general population (19) . Compared with controls, cases were slightly younger and were more likely to have been born outside of Australia/New Zealand, to have obtained a university degree, to have a family history of breast cancer, to have a later age at first birth, to have taken estrogen and progesterone combination hormone replacement therapy, and to have weighed less than their peers at age 30 years (Table 1 ). In addition, cases were less likely than controls to have had 1 or more children, to have breastfed their children, and to be postmenopausal. There was no evidence of any associations between sleep duration (on either workdays or nonworkdays), sleep quality, or combined duration/quality and risk of breast cancer in either the age-adjusted models or the fully adjusted models ( Table 2 ). The fully adjusted odds ratios for the association between sleep duration on workdays and breast cancer were 1.05 (95% confidence interval (CI): 0.82, 1.33) for <6 hours, 0.96 (95% CI: 0.80, 1.16) for 6-7 hours, and 1.10 (95% CI: 0.87, 1.39) for >8 hours, as compared with the reference category of 7-8 hours. Retaining the <5 and >9 hours-of-sleep groups in the logistic regression analysis did not appreciably alter the odds ratios or provide any evidence of trends.
Polytomous analysis examining differential risks for preand postmenopausal cancer (Table 3 ) and estrogen receptorpositive and -negative tumors (Table 4 ) also showed no association with sleep duration, sleep quality, or risk of breast cancer subtype.
Stratified analysis investigating the impact of circadian rhythm (phase, amplitude, and stability) on the relationships among duration of sleep on workdays (Table 5 ), sleep quality (Table 6) , and the risk of breast cancer also showed no relationships. There was weak evidence to support the appearance of a U-shaped relationship between sleep duration and breast cancer risk when the analysis was restricted to women who were scored as vigorous types on the languidness/vigorousness scale. There was also weak evidence to suggest a trend of increasing risk with decreasing sleep quality when the analysis was restricted to women who were scored as languid types on the languidness/vigorousness scale.
Age-stratified analysis did not provide any evidence of differential risk by age (data not shown).
Sensitivity analyses
Under the sensitivity analyses, 3 of the 7 scenarios produced strong, statistically significant results. First, if we assumed that all nonparticipants slept for 7-8 hours per b P value for the difference between estrogen receptor-positive and estrogen receptor-negative cancer risk. c Adjusted for age, number of children, age at first birth, breastfeeding, menopausal status, use of hormone replacement therapy, duration of use of hormone replacement therapy, alcohol consumption, comparative weight at age 30 years, ever use of melatonin, and physical activity. sleepers. Third, if we assumed that nonconsenters slept for less than 6 hours while nonresponders slept 7-8 hours, the age-adjusted odds ratio for less than 6 hours was 1.03 (95% CI: 0.90, 1.17); the odds ratio for 6-7 hours was 1.48 (95% CI: 1.27, 1.72); and the odds ratio for more than 8 hours was 1.70 (95% CI: 1.38, 2.09), compared with the reference category of 7-8 hours. None of the other sensitivity scenarios were statistically significant. Misclassification of sleep duration on workdays and the sleep quality of 10%, 20%, and 50% of participants were investigated, but the odds ratios for risk of breast cancer were not appreciably altered (data not shown). 
DISCUSSION
This study found no association between self-reported sleep duration on workdays, sleep duration on nonworkdays, subjective sleep quality, or combined duration and quality and risk of breast cancer. Polytomous analysis examining differential risks for breast cancer by menopause and the estrogen receptor status of cases also showed no association of sleep duration or quality with risk of breast cancer. In addition, stratification by circadian rhythm showed no association between sleep duration and breast cancer, although there was weak evidence for a possible association between sleep duration and breast cancer in women scored as more vigorous types on the languidness/vigorousness scale and between sleep quality and breast cancer in women scored as more languid types on the scale.
These results are consistent with those of a number of other studies. In a study of subjective sleep quality and breast cancer risk, Verkasalo et al. (22) also found no association. Three of 5 studies that investigated the relationship between sleep duration and breast cancer (22, 25, 26) found no relationship, while the 2 remaining studies produced conflicting results (23, 24 (24) . Among the 5 studies described above, 4 found stronger results in subanalyses (22, (24) (25) (26) . When analyses were restricted to stable sleepers, Verkasalo et al. (22) reported a statistically significant decreasing trend between sleep duration and breast cancer risk, while Pinheiro et al. (25) reported a statistically significant increasing trend. Wu et al. (26) found a statistically significant trend of decreasing breast cancer risk with increasing sleep duration in postmenopausal women, but this trend did not differ significantly from that in premenopausal cases. The very small increasing risk reported by McElroy et al. became stronger in cases with more advanced disease in polytomous models, but the comparison between localized and regional/distant cases was not statistically significant (24) .
Previous studies have not assessed the role of circadian rhythm in breast cancer risk. If the associations found in this study are true, they are somewhat contradictory. On the languidness/vigorousness scale, languidness is associated with higher levels of impairment following disruption of sleep in comparison with vigorousness (32, 33) . It could a Phase (morningness/eveningness), amplitude (languidness or vigorousness), and stability (the flexibility or rigidity of sleeping habits).
b Adjusted for age, number of children, age at first birth, breastfeeding, menopausal status, use of hormone replacement therapy, duration of use of hormone replacement therapy, alcohol consumption, comparative weight at age 30 years, ever use of melatonin, physical activity, country of birth, highest level of education, family history of breast cancer, previous noncancerous breast conditions, use of oral contraceptives in the last 5 years, and ever smoking tobacco.
c Seventeen participants were missing data on circadian phase, 20 were missing data on amplitude, and 21 were missing data on stability.
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Am J Epidemiol. 2013;177(4):316-327 be hypothesized that these impairments in languid types of persons may extend to physiological processes associated with the development of cancer. We saw a weak association between sleep quality and breast cancer risk in languid types which appears to support this. However, under this hypothesis, one would not expect our finding of a (weak) increased risk with duration of sleep for vigorous types.
It is unclear why studies of sleep duration and breast cancer have found such conflicting results. Differing data collection and analysis methods may go some way toward explaining this. In particular, the studies differed in terms of the information they collected ("current" sleep duration as compared with "usual" sleep duration) and whether the analysis was restricted by participant trait.
The strengths of this large population-based case-control study include distinguishing between sleep durations on workdays and nonworkdays and including subjective sleep quality, which has been investigated in only 1 other study. In addition, our study is the first (to our knowledge) to have investigated the role of circadian rhythm in breast cancer risk.
One weakness of this study was that sleep duration and sleep quality were self-reported, and misclassification was possible. While the questionnaire we used has been shown to be reliable (45) , it showed only poor validity in comparison with wrist actigraphy in a small validation study (43) . The lack of association between subjectively and objectively measured sleep has been recognized as a problem and is an ongoing issue, particularly for epidemiologists, for whom subjectively measured sleep is the only practical option in large studies. While it is possible that a true association in this study might have been masked by misclassification, our analyses of the potential effect of exposure misclassification showed that the odds ratios were not appreciably altered. The low response fraction, particularly for controls, had the potential to introduce selection bias into the study. Selection bias could account for these results if nonparticipants experienced different sleep duration and quality than participants. Sensitivity analysis found 3 scenarios under which the results would provide evidence for an association. The ageadjusted odds ratios under the assumption that all nonparticipants slept for 7-8 hours on workdays showed a strong U-shaped distribution. The assumption that nonconsenters all slept for less than 6 hours and that nonresponders all slept 7-8 hours on workdays also showed results that were statistically significant, although the U-shaped distribution was not as strong. The age-adjusted odds ratios under the assumption that all nonparticipants were very good sleepers showed an increasing trend with decreasing quality. However, this relationship was not present under the assumption that all nonparticipants were only fairly good sleepers. While this analysis highlights the potential for selection bias, the assumptions on which these 3 scenarios were based were the most conservative.
Recall bias is less likely to have affected the results, since sleep is not widely recognized by the public as a possible risk factor for cancer, and in order for recall bias to have produced the results found in this study, cases would have had to be underreporting and/or controls overreporting exposure to short/long sleep duration and poor sleep quality.
In summary, this study does not provide evidence to support an association between self-reported sleep duration or quality and the risk of breast cancer. The ongoing issue of how best to measure sleep in epidemiologic studies needs to be addressed. a Phase (morningness/eveningness), amplitude (languidness or vigorousness), and stability (the flexibility or rigidity of sleeping habits).
b Adjusted for age, number of children, age at first birth, breastfeeding, menopausal status, use of hormone replacement therapy, duration of use of hormone replacement therapy, alcohol consumption, comparative weight at age 30 years, ever use of melatonin, and physical activity.
